Home/Filings/4/0001209191-21-056459
4//SEC Filing

Brinkley Ruth Williams 4

Accession 0001209191-21-056459

CIK 0001438533other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 6:16 PM ET

Size

7.3 KB

Accession

0001209191-21-056459

Insider Transaction Report

Form 4
Period: 2021-09-14
Transactions
  • Award

    Common Stock

    2021-09-14+5,2505,250 total
  • Award

    Stock Option (Right to Buy)

    2021-09-14+15,75015,750 total
    Exercise: $23.61Exp: 2031-09-13Common Stock (15,750 underlying)
Footnotes (1)
  • [F1]One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter.

Issuer

Travere Therapeutics, Inc.

CIK 0001438533

Entity typeother

Related Parties

1
  • filerCIK 0001344381

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:16 PM ET
Size
7.3 KB